Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate

Mälkönen, 1980, Effects of danazol and lynestrenol on serum lipoproteins in endometriosis, Clin Pharmacol Ther, 28, 602, 10.1038/clpt.1980.209 Allen, 1981, Cholesterol, high density lipoprotein and danazol, J Clin Endocrinol Metab, 53, 149, 10.1210/jcem-53-1-149 Fåhraeus, 1984, Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women, Fertil Steril, 42, 52, 10.1016/S0015-0282(16)47957-4 Hirvonen, 1981, Effects of different progestogens on lipoproteins during postmenopausal replacement therapy, N Engl J Med, 304, 560, 10.1056/NEJM198103053041002 Fåhraeus, 1983, L-norgestrel and progesterone have different influences on plasma lipoproteins, Eur J Clin Invest, 13, 447, 10.1111/j.1365-2362.1983.tb00127.x Tikkanen, 1981, Different effects of two progestins on plasma high density lipoprotein2 (HDL2) and postheparin plasma hepatic lipase activity, Atherosclerosis, 40, 365, 10.1016/0021-9150(81)90147-7 Wallentin, 1981, HDL3 and HDL2 determination by a combined ultracentrifugation and precipitation procedure, Clin Chim Acta, 116, 199, 10.1016/0009-8981(81)90023-1 Jeppson, 1976, Serum levels of medroxyprogesterone acetate and estradiol and plasma levels of FSH and LH in women after intramuscular administration of Depo-Provera, Contraception, 14, 461, 10.1016/S0010-7824(76)80060-1 Larsson-Cohn, 1981, Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive, Fertil Steril, 35, 172, 10.1016/S0015-0282(16)45318-5 Crona, 1983, High-dose depot-medroxyprogesterone acetate (DMPA)—effects on lipid and lipoprotein metabolism, Eur J Obstet Gynecol Reprod Biol, 16, 97, 10.1016/0028-2243(83)90106-5 Grönroos, 1983, Effect of high dose progestin on serum lipids, Atherosclerosis, 47, 101, 10.1016/0021-9150(83)90077-1 Fåhraeus, 1983, High density lipoprotein subfractions during oral and cutaneous administration of 17β-estradiol to menopausal women, J Clin Endocrinol Metab, 56, 797, 10.1210/jcem-56-4-797 Larsson-Cohn, 1986, Effect on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drug, Acta Obstet Gynecol Scand., 10.3109/00016348609158366 Hesselius, 1981, Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study, Acta Obstet Gynecol Scand (Suppl), 101, 65, 10.3109/00016348109157815 Sall, 1979, A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma, Am J Obstet Gynecol, 135, 647, 10.1016/S0002-9378(16)32990-8